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ABSTRACT 
Due to worldwide phenomenon of microbial resistance to 
commonly used therapeutic agents, antibiotics and antifungals, 
dibasic di-/trimethylphenylcarbamic acid esters 1–3, a non-
-traditional series of potential antimicrobials, has been in vitro 
evaluated against chosen gram-positive (Staphylococcus aureus) 
and gram-negative (Escherichia coli) bacterial strains as well as 
against yeast (C. albicans) by the minimum inhibitory 
concentration (MIC) assay. Taking into consideration chemical 
structure of tested derivatives, the incorporation of more than one 
protonated atom of nitrogen into salt forming fragment positively 
influenced the activity against E. coli. On the contrary, the 
presence of one or more methyl groups instead of 3-alkoxy side 
chain attached to lipophilic aromatic moiety has not found to be 
favorable structural feature. In entire set of inspected compounds, 
the most promising results have been found for the compound          
3, chemically 1-[3-piperidinium-1-yl-2-({[(2,4,6-trimethylphen-
yl)amino]carbonyl}oxy)propyl]piperidinium dichloride, against 
E. coli with the MIC=1.56mg/mL. 
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INTRODUCTION 
The widespread use of antibiotics has 
resulted in the emergence of multidrug-resistant 
bacterial pathogens. The prevalence and rate 
of antimicrobial resistance among important 
gram-positive and gram-negative pathogens has 
been progressive and relentless. Ten years ago, 
concern centred on gram-positive bacteria, 
particularly methicillin (oxacillin)--resistant 
Staphylococcus aureus and vancomycin--resistant 
Enterococcus spp. Now, however, clinical 
microbiologists increasingly agree that 
multidrug-resistant gram-negative bacteria pose 
the greatest risk to public health. Classic agents 
used to treat these pathogens have become 
outdated. Of the few new drugs available, many 
have already become targets for bacterial 
mechanisms of resistance (Kanj and Kanafani, 
2011; Li et al., 2015; Moran et al., 2006; Rodvold 
and McConeghy, 2014). 
It has been reported that the use of local 
anaesthesia may interfere with microbial 
assessment of tissue samples or culture 
specimens taken from patients with local 
infection because of the anaesthetics´ 
antimicrobial action. Local anaesthetics (LAs) 
have been known to bind specifically to the cell 
membranes of bacteria and to alter their 
structure and fluidity, to disrupt membrane 
potential and to inhibit membrane-bound 
respiratory function (Collura and Letellier, 
1990). Lidocaine (lidocainium chloride; Figure 
1) is the most studied active agent which has 
been included in this pharmacotherapeutic class 
(Begec et al., 2007; Gocmen et al., 2008; Lu 
et al., 2014). In historical terms, there have been 
three definitive papers describing, in turn, the 
chemistry, pharmacology and clinical features 
of lidocaine – research of Löfgren and 
Lundquist (1946), Goldberg (1949) and 
Gordh (1949). 
The compounds under current study 1–3 
have shown structural similarity to the molecule 
of lidocaine – a typical structural arrangement 
for LAs. Particularly, the substances 1–3 have 
contained (i) lipophilic alkyl substituted 
aromatic ring, polar carbamate moiety attached 
to (ii) branched hydrocarbon connecting chain 
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and (iii) salt forming fragment containing 
nitrogen(s) as well, as can be seen in figure 1. 
The goal of current research was to 
in vitro investigate the efficiency of given 
alkylphenylcarbamic acid esters against gram-
-positive bacteria Staphylococcus aureus ATCC 
6538 (Micrococcaceae), gram-negative bacteria 
Escherichia coli CNCTC 377/79 (Entero- 
bacteriaceae) and yeast Candida albicans CCM 8186 
as well and try to identify some structural 
features which could be beneficial in terms 
of their potency. 
 
MATERIALS AND METHODS 
The compounds under the study 
The evaluated  compounds 1–3 (Figure 1), 
chemically 1-[3-pyrrolidinium-1-yl-2-({[(2,6-
-dimethylphenyl)amino]carbonyl}oxy) propyl]-
pyrrolidinium dichloride (1), 1-[3-piperidinium-
-1-yl-2-({[(2,6-dimethylphenyl)amino]carbonyl} 
oxy)propyl]piperidinium dichloride (2) and 
1-[3-piperidinium-1-yl-2-({[(2,4,6-trimethyl- 
phenyl)amino]carbonyl}oxy)propyl]piperidin-
ium dichloride (3), were purchased from 
Department of Chemical Drugs, Faculty 
of Pharmacy, University of Veterinary and 
Pharmaceutical Sciences in Brno, Czech 
Republic. 
 
The in vitro antimicrobial activity assay 
Microorganisms 
Antimicrobial properties of tested 
molecules 1–3 were investigated against gram-
-positive bacteria S. aureus ATCC 6538 
(Micrococcaceae), gram-negative bacteria E. coli 
CNCTC 377/79 (Enterobacteriaceae) and yeast C. 
albicans CCM 8186 as well. The tested bacterial 
strains were purchased from American Type 
Culture Collection (Manassas, United States 
of America) and Czech National Collection 
of Type Cultures (Prague, Czech Republic); 
yeast was obtained from Czech Collection 
of Microorganisms (Brno, Czech Republic). 
 
Culture media 
For a cultivation of the microorganisms, 
listed in the previous section of this paper, 
a blood agar, Endo agar and Sabouraud’s agar 
(Imuna, Šarišské Michaľany, Slovak Republic) 
were used. Blood agar was prepared by adding 
10% of defibrine sheep’s blood to melted and 
cooled (50ºC) competent components. 
 
 
 
Figure 1. Chemical structure of lidocaine (lidocainium chloride) and  dibasic esters of phenylcarbamic  
acid under the study 
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Determination of minimum inhibitory 
concentration (MIC) 
The MIC readouts of the moleculs 1–3 
were carried out by following the procedure 
previously published in literature (Csöllei et al., 
2014). 
The respective test compounds were 
dissolved in distilled water. Standard 
suspension of bacteria was prepared from their 
24h cultures which were cultivated on a blood 
agar (gram-positive bacteria) and endo agar 
(gram-negative bacteria). Standard suspension 
of Candida was prepared from its 48h cultures 
cultivated on Sabouraud’s agar. 
Prepared suspension contained the 
concentration of 5×107 colony forming units 
(CFU) per mL of bacteria and 5×105CFU/mL 
of Candida, respectively. The UV/VIS 
spectrophotometry was used for the 
determination of the microorganisms 
concentration. For the measurements, the 
UV/VIS range spectrophotometer Jenway, 
model 6305 (United Kingdom) was carried out. 
All evaluated suspensions were adjusted to the 
absorbance value of 0.35 at the wavelength 
of 540nm. 
The suspension of the microorganisms 
was added in the amount of 5μL into the 
solutions of inspected compounds (100μL) and 
to double concentrated peptone broth medium 
(8%) for bacteria or to Sabouraud’s medium 
(12%) for Candida. The peptone broth and 
Sabouraud’s media were purchased from Imuna 
(Šarišské Michaľany, Slovak Republic). 
Starting concentration of prepared stock 
solutions was 50.00mg of respective compound 
per mL of distilled water. These stock solutions 
(5%) were then serially diluted by a half and 
final concentrations were 25.00, 12.50, 6.25, 
3.13, 1.56, and 0.78mg/mL, respectively. 
 
Quantitative screening 
The quantitative screening was 
performed using sterile 96-well plastic 
microtiter plates (with round-bottomed wells) 
with matching covers. Microorganisms were 
incubated in each well at 37°C for 24h. Upon 
completion of this process, the volume of 5μL 
of evaluated suspension has been taken from 
each well by using transferring tool and 
cultured on a blood agar (S. aureus), Endo agar 
(E. coli) or on Sabouraud’s agar (C. albicans), 
respectively. Petri dishes were then incubated 
for 24h at 37°C. 
The positive control using only 
an inoculation of microorganisms and the 
negative control of solvent were realized 
parallelly. The nutrient concentration remained 
stable in each well, only the concentration 
of inhibitory compound changed. All 
experiments were performed in triplicate. 
The MIC was regarded as the lowest 
concentration of antimicrobial agent required 
to inhibit the visible growth of microorganism 
after incubation (Andrews, 2001). The MIC was 
dependent on the presence/absence of the 
culture on used solid media after the transfer 
of 5μL of suspension from each well. 
Estimated MIC readout was dependent on the 
presence/absence of the culture on used solid 
media after the transfer of 5μL of suspension 
from each well. The MICs are reported 
in Table I in mg/mL units. 
 
RESULTS AND DISCUSSION 
Following chemical structure 
of currently in vitro screened compounds 1–3, 
their antimicrobial activity has been dependent 
on: (i) type, number and position of the 
substituents attached to phenyl ring 
in lipophilic part, (ii) type and number of 
protonatable basic centres in salt forming 
moiety. Possible impacts of given structural 
aspects were discussed in next sections of the 
paper. 
Current preliminary results have outlined 
that all the investigated compounds have 
shown relatively improved activity against 
gram-negative bacteria when compared to their 
potency against the gram-positive one or 
anticandidacidal efficiency, as can be seen 
in table. I 
Previous research of Csöllei et al. (2014) 
has indicated that incorporation of 2-alkoxy- 
phenyl moiety (where alkoxy=butoxy to 
hexyloxy) instead of current 2,6-dimethyl- 
or 2,4,6-trimethylphenyl ones has led to 
inconclusive effect of thus molecules against 
given microorganisms. On the contrary, the 
substitution by alkoxy side chain at 3-position 
has meant notable increasing in the potency 
of such compounds. The authors have also 
proposed their possible mechanisms of action. 
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The electronic nature, steric hindrance 
and lipohydrophilic properties have been 
believed to be important, in order to explain 
the function of substituents in position 2 and 6 
or 2, 4 and 6, respectively (Figure 1). It has 
been reported that lidocaine has rapidly 
inhibited the generation of membrane potential 
in the inverted membrane vesicles of bacteria. 
It has been suggested that inhibition of 
membrane potential might contribute to the 
killing of bacteria, and that outer membrane 
changes might facilitate access to the inner 
membrane as a major target of killing (Garlid 
and Nakashima, 1983; Ohsuka et al., 1994). 
Following chemical structures of the 
molecules under current study, it could be 
supposed that practically free rotation around 
the Carom–N bond (Figure 1) could be possible, 
as reported in previous research (Remko, 1989) 
which has dealt ab initio and quantum-chemical 
PCILO investigations of tocainide, 
a structurally very similar molecule due to the 
presence of 2,6-dimethylphenylaminocarbonyl 
group. Experimental X-ray values for the 
torsion angle α in the salts of lidocaine (Hanson 
and Röhrl, 1972; Yoo et al., 1975) have been 
in the range of 64–71.5º. It could be also 
possible that, while keeping 2,6-dimethylphenyl 
moiety, relative position of nitrogen atoms 
of salt forming groups and „amidic“ proton 
have been different (perhaps not quite optimal) 
compared to their arrangement in the molecule 
of lidocaine (Hanson and Banner, 1974). 
Furthermore, in the structure of 
currently tested compounds 1–3, the presence 
of more polar carbamoyloxy bond instead 
of the „classical“ anilide one has influenced 
possible linkage of the molecules into chains 
through N–H · · · O bonding (Gowda et al., 
2007). For comprehensiveness, no interaction 
between methyl groups and NH-moiety has 
been observed (Gowda et al., 2007; Gowda et 
al., 2008). 
It could be assumed that isosteric 
replacement of anilide fragment, the presence 
of two centres of protonation – pyrrolidinium 
or piperidinium moieties simultaneously with 
the absence of highly lipophilic alkoxy group 
attached to phenyl ring, has led to more 
complicated internalization of inspected 
derivatives into bacterial outer membrane. 
Given factors have resulted in relatively higher 
values of MIC, as can be seen in Table I. 
It was stated that the molecules 1–3 have 
been regarded as relatively promising against 
gram-negative E. coli. It could be supposed that 
pyrrolidinium or piperidinium groups would be 
the most eligible proton donors in specific 
(drug–receptor) interactions between exposed 
phosphoryl and carboxyl groups of highly 
negatively charged outer face of bacterial outer 
membrane (Csöllei et al., 2014). Due to the 
negative charge of phosphate or carboxylate, 
the hydrogen bond would be fairly strong. That 
bond type could potentially lead to 
conformational changes within membrane. It 
was also interesting taking into account the 
conformation in which hydrogen atom of the 
charged „amine“ group has been to main 
backbone of the molecule. For instance, the 
activity of lidocaine-type molecules, which have 
contained saturated ring with amine N atom 
and substitution of a Cα atom, have been 
dependent on thus position: trans position to 
the main backbone has been responsible for 
antiarrhythmic activity, while gauche 
conformation has promoted local anaesthetic 
action (Główka and Olczak, 1999; Główka 
et al., 2005). 
Current results have revealed that 
increasing in the lipophilicity due to 
incorporation of six-membered piperidinium 
cycles (compounds 2 and 3) instead of the            
five-membered pyrrolidinium ones (1) has 
meant slight improvement in the activity 
(Table I). 
Table I. The in vitro efficiency of inspected compounds 1–3 against selected microorganisms 
 
Entry 
MIC (mg/mL) 
S. aureus E. coli C. albicans 
1 25.00 25.00 25.00 
2 25.00 3.13 25.00 
3 25.00 1.56 12.50 
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CONCLUSION 
Assuming a maintenance of fundamental 
structural motif of dibasic phenylcarbamic acid 
esters, for notable efficacy of these compounds 
against gram-positive and gram-negative 
bacteria, the presence of lipophilic alkoxy side 
chain, which has contained more than four 
carbon atoms, have been regarded as essential. 
Furthermore, given fragment should be 
attached to 3-position of phenyl ring. The 
replacement of thus chain for one or more 
methyl groups has led to pronounced decrease 
in the activity, despite structural similarity 
of these molecules with antimicrobially efficient 
lidocaine. The conformation in which hydrogen 
atom of the charged amine group has been to 
the main backbone could be considered 
essential. 
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